These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30992659)

  • 1. A first-in-human study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of KM-819 (FAS-associated factor 1 inhibitor), a drug for Parkinson's disease, in healthy volunteers.
    Shin W; Lim KS; Kim MK; Kim HS; Hong J; Jhee S; Kim J; Yoo S; Chung YT; Lee JM; Cho DY
    Drug Des Devel Ther; 2019; 13():1011-1022. PubMed ID: 30992659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, Pharmacokinetics, and Pharmacodynamics of ME-401, an Oral, Potent, and Selective Inhibitor of Phosphatidylinositol 3-Kinase P110δ, Following Single Ascending Dose Administration to Healthy Volunteers.
    Moreno O; Butler T; Zann V; Willson A; Leung P; Connor A
    Clin Ther; 2018 Nov; 40(11):1855-1867. PubMed ID: 30458930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of a Neuroprotective Poly (ADP-ribose) Polymerase-1 Inhibitor, JPI-289, in Healthy Volunteers.
    Han S; Kim YH; Choi HY; Soh DJ; Kim J; Nam J; Kim JW; Bae KS; Lim HS
    Drug Des Devel Ther; 2020; 14():3189-3199. PubMed ID: 32801651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, Safety, and Tolerability of Orally Administered Ursodeoxycholic Acid in Patients With Parkinson's Disease-A Pilot Study.
    Sathe AG; Tuite P; Chen C; Ma Y; Chen W; Cloyd J; Low WC; Steer CJ; Lee BY; Zhu XH; Coles LD
    J Clin Pharmacol; 2020 Jun; 60(6):744-750. PubMed ID: 32052462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple-Ascending Dose Study in Healthy Subjects to Assess the Pharmacokinetics, Tolerability, and CYP3A4 Interaction Potential of the T-Type Calcium Channel Blocker ACT-709478, A Potential New Antiepileptic Drug.
    Richard M; Kaufmann P; Ort M; Kornberger R; Dingemanse J
    CNS Drugs; 2020 Mar; 34(3):311-323. PubMed ID: 31994022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple-Ascending-Dose Pharmacokinetics and Safety Evaluation of Baicalein Chewable Tablets in Healthy Chinese Volunteers.
    Pang H; Xue W; Shi A; Li M; Li Y; Cao G; Yan B; Dong F; Xiao W; He G; Du G; Hu X; Cheng G
    Clin Drug Investig; 2016 Sep; 36(9):713-724. PubMed ID: 27352310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of safinamide, a neuroprotectant with antiparkinsonian and anticonvulsant activity.
    Marzo A; Dal Bo L; Monti NC; Crivelli F; Ismaili S; Caccia C; Cattaneo C; Fariello RG
    Pharmacol Res; 2004 Jul; 50(1):77-85. PubMed ID: 15082032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, safety, and tolerability of GLPG0259, a mitogen-activated protein kinase-activated protein kinase 5 (MAPKAPK5) inhibitor, given as single and multiple doses to healthy male subjects.
    Namour F; Vanhoutte FP; Beetens J; Blockhuys S; De Weer M; Wigerinck P
    Drugs R D; 2012 Sep; 12(3):141-63. PubMed ID: 22950522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability, safety, pharmacokinetics and pharmacodynamics of SHR0534, a potent G protein-coupled receptor 40 (GPR40) agonist, at single- and multiple-ascending oral doses in healthy Chinese subjects.
    Zhao Y; Xie L; Ou N; Wu J; Zhang H; Zhou S; Liu Y; Chen J; Wang L; Wang L; Wang J; Shao F
    Xenobiotica; 2021 Mar; 51(3):297-306. PubMed ID: 33331206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, Tolerability and Pharmacokinetics of Yimitasvir Phosphate Capsule, a Novel Oral Hepatitis C Virus NS5A Inhibitor, in Healthy Chinese Volunteers.
    Zhao N; Xie R; Zhao X; Zhao H; Jia B; Zhang Y; Luo L; Huang Z; Li J; Wang X; Yan H; He B; Xie H; Ren Q; Cui Y
    Clin Drug Investig; 2019 Jul; 39(7):671-681. PubMed ID: 31079356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single- and Multiple-dose Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP1128, a Novel Peroxisome Proliferator-activated Receptor δ Modulator, in Healthy Participants.
    Taniuchi Y; van Till JWO; Wojtkowski T; Toyoshima J; Koibuchi A; Sargent B; Han D
    Clin Pharmacol Drug Dev; 2023 Aug; 12(8):810-818. PubMed ID: 36942507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
    Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
    Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics, Safety, and Tolerability of Multiple Doses of the Novel Oxytocin Receptor Antagonist Cligosiban in Development for Premature Ejaculation: Two Randomized Clinical Trials in Healthy Subjects.
    Muirhead GJ; Osterloh IH; Whaley S; van den Berg F
    J Sex Med; 2019 Feb; 16(2):213-222. PubMed ID: 30612858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects.
    Taylor L; Gidal B; Blakey G; Tayo B; Morrison G
    CNS Drugs; 2018 Nov; 32(11):1053-1067. PubMed ID: 30374683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A first-in-human study to evaluate the safety, tolerability and pharmacokinetics of RP3128, an oral calcium release-activated calcium (CRAC) channel modulator in healthy volunteers.
    Barde PJ; Viswanadha S; Veeraraghavan S; Vakkalanka SV; Nair A
    J Clin Pharm Ther; 2021 Jun; 46(3):677-687. PubMed ID: 33314326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, Tolerability, and Pharmacokinetics of Ibuprofenamine Hydrochloride Spray (NSAIDs), a New Drug for Rheumatoid Arthritis and Osteoarthritis, in Healthy Chinese Subjects.
    Xie P; Xue W; Qi W; Li Y; Yang L; Yang Z; Shi A
    Drug Des Devel Ther; 2021; 15():629-638. PubMed ID: 33628011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, safety and tolerability of Bencycloquidium bromide, a novel selective muscarinic M1/M3 receptor antagonist, after single and multiple intranasal doses in healthy chinese subjects: an open-label, single-center, first-in-human study.
    Sun L; Ding L; Wang Y; Zhou W; Yan Z; Sun W; Zhang H; Ou N; Chen X
    Drugs R D; 2012 Mar; 12(1):17-28. PubMed ID: 22339483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, Pharmacodynamics, and Safety of Rasagiline Transdermal Patch: A Preliminary Study in Healthy Chinese Subjects.
    Zhou W; Lv C; Zhang Q; Zong S; Wang M
    Clin Drug Investig; 2018 Feb; 38(2):125-133. PubMed ID: 29159774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Dopamine D1 Receptor Partial Agonist, PF-06669571, in Subjects with Idiopathic Parkinson's Disease.
    Gurrell R; Duvvuri S; Sun P; DeMartinis N
    Clin Drug Investig; 2018 Jun; 38(6):509-517. PubMed ID: 29478239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, Safety, and Tolerability Following Single and Multiple Doses of Pibrentasvir in a First-in-Human Study.
    Lin CW; Dutta S; Asatryan A; Wang H; Clifton J; Campbell A; Liu W
    Clin Pharmacol Drug Dev; 2018 Jan; 7(1):44-52. PubMed ID: 28464496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.